Contact Information: Contacts: Fern Lazar Lazar Partners (212) 867-1762 Mark Sahl Lazar Partners (609) 992-5205
PDL BioPharma Appoints Christine Larson as VP and CFO
| Source: PDL BioPharma
INCLINE VILLAGE, NV--(Marketwire - December 18, 2008) - PDL BioPharma, Inc. (PDL) (NASDAQ : PDLI ) today announced that its board of directors has appointed Christine
Larson, CPA, as its vice president and chief financial officer (CFO).
Larson brings more than 20 years of experience as a financial professional
to the role.
"Cris began working for PDL in early October on a consulting basis, and we
are pleased that she has accepted this key position following today's
completion of the spin-off of our biotechnology assets," said John
McLaughlin, president and chief executive officer of PDL. "Her background
in corporate finance and investment banking brings a breadth of experience
that furthers our ability to manage our royalty assets and maximize PDL's
return to its stockholders."
Previously, Larson served as a senior manager/director at Grant Thornton,
LLP in their Mergers and Acquisitions Advisory group. Prior to that time,
Larson was chief financial officer for TWL Corporation, a publicly held,
technology-enabled learning company. From 1985 to 1998, Larson was with
Bank of America Corporation, most recently as a senior vice president and
managing director and was responsible for business development in their
Global Capital Markets group. In this role, she established Bank of
America's equity derivatives business and structured a strategic alliance
with a major New
York-based investment firm involving a $1 billion plus recapitalization of
the firm.
Until June 2008, she served as a Board Officer and Vice President of
Finance for the California Alumni Association, University of California,
Berkeley. Larson also serves on the Audit Committee for George Mark
Children's House. She received a B.S. in Food and Nutritional Sciences from
the University of California, Berkeley, and an M.B.A. from California State
University, East Bay. Larson is a Certified Public Accountant in the State
of California.
About PDL BioPharma
PDL BioPharma pioneered the humanization of monoclonal antibodies and, by
doing so, enabled the discovery of a new generation of targeted treatments
for cancer and immunologic diseases. The company is focused on maximizing
the value of its antibody humanization patents and related assets. For more
information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of
PDL BioPharma, Inc.